296 related articles for article (PubMed ID: 36168628)
1. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
2. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p.
Lin H; Zuo D; He J; Ji T; Wang J; Jiang T
Oncol Res; 2021 Mar; 28(6):591-603. PubMed ID: 32838835
[TBL] [Abstract][Full Text] [Related]
3. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
Lung Cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
Cui S
J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
Geng S; Tu S; Fu W; Wang J; Bai Z
Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
[TBL] [Abstract][Full Text] [Related]
7. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
8. M
Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
[TBL] [Abstract][Full Text] [Related]
9. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
10. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
[TBL] [Abstract][Full Text] [Related]
11. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
Liu HT; Zou YX; Zhu WJ; Sen-Liu ; Zhang GH; Ma RR; Guo XY; Gao P
Cell Death Differ; 2022 Mar; 29(3):627-641. PubMed ID: 34608273
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation.
Xie R; Liu L; Lu X; He C; Yao H; Li G
Gastric Cancer; 2024 Jan; 27(1):49-71. PubMed ID: 37897508
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
15. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract][Full Text] [Related]
16. CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.
Yang P; Zhang D; Wang T; Ji J; Jin C; Peng C; Tan Y; Zhou J; Wang L; Feng Y; Sun Y
Cell Death Dis; 2022 Sep; 13(9):796. PubMed ID: 36123327
[TBL] [Abstract][Full Text] [Related]
17. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
[TBL] [Abstract][Full Text] [Related]
18. YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
Zhu J; Tong H; Sun Y; Li T; Yang G; He W
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108067
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination.
Zeng FL; Lin J; Xie X; Xie YK; Zhang JH; Xu D; He X; Liu FE; Xie BH
Neoplasma; 2023 Jun; 70(3):361-374. PubMed ID: 37498069
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.
Wang Z; Han Y; Li Q; Wang B; Ma J
Brain Behav; 2021 Oct; 11(10):e2321. PubMed ID: 34536977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]